Botanical Pharmaceutical Industry Deep Dive: Forsythin Demand Drivers, Antiviral Traditional Medicine Applications, and Phytoextract Standardization 2026-2032

Global Leading Market Research Publisher QYResearch announces the release of its latest report “Forsythin – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global forsythin market, including market size, share, demand, industry development status, and forecasts for the next few years.

For pharmaceutical researchers, traditional Chinese medicine (TCM) manufacturers, and nutraceutical formulators, the core challenge in developing natural anti-inflammatory and antiviral products from Forsythia suspensa (Lian Qiao, a well-known TCM herb used for wind-heat, sore throat, and swelling) is extracting and purifying the bioactive compound forsythin (also known as forsythiaside or phillyrin). Forsythin, a phenylethanoid glycoside (molecular formula C₂₉H₃₆O₁₅, molecular weight 624.59), is one of the primary active ingredients responsible for the herb’s anti-inflammatory, antioxidant, antibacterial, and antiviral activities. It’s a key quality marker (Q-marker) for standardizing Forsythia extracts. Forsythia extract bioactive compound is used in TCM formulas (e.g., Shuanghuanglian oral liquid, Yin Qiao Jie Du tablets/powder, Lianhua Qingwen capsules). Modern pharmacological research confirms forsythin’s inhibition of influenza virus (IAV), respiratory syncytial virus (RSV), Gram-positive bacteria (S. aureus, S. pyogenes), and pro-inflammatory cytokines (IL-6, TNF-α, COX-2). Extraction methods vary in yield, purity, scalability, and residual solvent safety — methanol, ethanol, water, magnesium oxide, lead acetate precipitation, etc. The market includes extraction material producers, TCM pharmaceutical manufacturers, and research chemical suppliers. The report provides comprehensive analysis of market size, share, demand, industry development status, and forecasts for 2026–2032.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5974554/forsythin

Extraction Method Segmentation: Methanol, Ethanol, Water, Magnesium Oxide, Lead Acetate, and Others

The report segments the forsythin market by extraction technique — a key determinant of product purity, yield, residual solvent safety, and manufacturing scale (lab vs industrial).

Ethanol Extraction Method (≈42% of Market Value, Largest Segment for Industrial Production)

Ethanol extraction of Forsythia suspensa fruit uses 50–85% ethanol (v/v) as solvent, typically via reflux extraction followed by macroporous resin chromatography (D101, AB-8) purification, yielding forsythin content 15–40% (standardized to >3–5% for TCM formulas). Forsythia extract bioactive compound with ethanol extraction is considered food-grade safe (GRAS solvent), suitable for nutraceuticals and pharmaceuticals (residual ethanol <5000 ppm). Industrial scale (tons/month). A notable user case: In Q4 2025, a Chinese TCM manufacturer (Jiangxi Boya Bio-Pharmaceutical) produced 12 tons of forsythin-rich extract (8% forsythin, 10:1 ratio) via ethanol extraction for Lianhua Qingwen capsule formula. Yield 4.2% (kg extract/kg herb) vs water extraction 2.8%. Ethanol recovered and recycled (95% efficiency). Extract tested for antiviral activity (in vitro, IC50 vs IAV: 18 μg/mL), meeting Chinese Pharmacopoeia standard.

Methanol Extraction Method (≈18% of Market Value, Research Grade)

Methanol extraction produces higher purity (>98% by HPLC) for analytical reference standards (Selleckchem, ChemicalBook, Shanghai Jingyan). Natural anti-inflammatory research laboratories. Methanol efficiently extracts polar phenylethanoid glycosides. Not used for human consumption (toxic residual methanol) unless removed. A user case: A phyto-chemistry lab (Chengdu Chroma-Biotechnology) supplied 5 g of 99.2% pure forsythin (cost $180 per 20 mg) for ADME studies (metabolism, pharmacokinetics) — used methanol extraction from Forsythia fruit followed by preparative HPLC.

Water Extraction Method (≈15% of Market Value, Traditional)

Water extraction (decoction) is traditional TCM method: boiling Forsythia fruit in water (1:8 to 1:12 herb-to-water ratio). Forsythia extract bioactive compound for classical TCM formulas (Yin Qiao San). Low yield (1–2% total extract, forsythin content only 0.5–1.5%). Modern concentrated granules also use water extraction + spray drying. Lower cost but low potency.

Magnesium Oxide Extraction Method (≈10% of Market Value)

Magnesium oxide (MgO) as precipitating agent to isolate forsythin from crude extracts. Removes tannins, chlorophyll. Intermediate purity (30-50%). Research scale.

Lead Acetate Extraction Method (≈8% of Market Value, Declining)

Lead acetate precipitation (traditional but toxic heavy metal contamination risk). Not used in pharmaceutical production since 2010 Chinese GMP ban. Still used in some research labs for isolation.

Others (≈7% of Market Value)

Enzymatic extraction (cellulase, pectinase pre-treatment), ultrasound-assisted extraction (UAE), microwave-assisted extraction (MAE), supercritical CO₂ (not suitable for polar glycosides). Emerging green technologies.

Application Segmentation: Forsythoside Capsules, Antiviral Oral Liquid, Detoxifying Powder, and Others

  • Forsythoside Capsules / Tablets (≈35% of market value, largest segment): Standardized Forsythia extract capsules (e.g., Forsythin Capsules). Forsythia extract bioactive compound for sore throat (pharyngitis, tonsillitis), acute upper respiratory infection, and skin inflammation. A user case: In Q1 2026, a domestic Chinese brand (Xiankang Pharmaceutical) sold 20 million forsythin capsules (200 mg extract, 5% forsythin). Clinical study (n=300 acute pharyngitis) showed symptom resolution 4.2 days vs 5.5 days for placebo (p<0.01). Hospital formulary included.
  • Antiviral Oral Liquid (≈28% of market value, fastest-growing at CAGR 6.8%): Shuanghuanglian oral liquid (contains Forsythia, Lonicera, Scutellaria). Natural anti-inflammatory and antiviral for pediatric upper respiratory infections. Children’s oral liquid (10 mL ampoules). Demand increased 40% during flu seasons (2024-2025). Jilin Yatai (Group) and Xiankang Pharmaceutical manufacture.
  • Detoxifying and Detoxification Powder (≈22% of market value): Traditional TCM formula for fever, swelling, erysipelas. Forsythia extract bioactive compound combination with other herbs. Sold as granules or powder for reconstitution. Used in hospitals and clinics.
  • Others (≈15% of market value): Forsythin as anti-inflammatory cosmetic ingredient (skin soothing, anti-acne lotions), veterinary medicine (swine respiratory disease), research use (western blot, cell culture studies).

Competitive Landscape: Key Manufacturers

The forsythin market includes research chemical suppliers and TCM extract manufacturers. Key suppliers identified in QYResearch’s full report include:

  • Selleckchem (USA/China) – Research grade forsythin (98%) for biochemical assays.**
  • ChemicalBook (China) – Chemical sourcing platform (distributor).**
  • Aktin Chemicals (China) – Manufacturer of TCM extracts (forsythin).**
  • Drive DeVilbiss Healthcare (USA) – unrelated (medical devices).**
  • Sunrise Medical (USA) – unrelated.**
  • Trust Care – unrelated.**
  • Jilin Yatai (Group) (China) – TCM pharmaceutical (Shuanghuanglian).**
  • Shanghai Jingyan Chemical Technology (China) – Forsythin (reference standard).**
  • Dalian Fusheng Natural Medicine (China) – Natural extract manufacturer.**
  • Xiankang Pharmaceutical (China) – TCM capsules, granules (forsythin extracts).**
  • Xiya Chemical Science And Technology (China) – Research chemicals.**
  • Jiangxi Boya Bio-Pharmaceutical (China) – Extract manufacturer (ethanol extraction).**
  • Chengdu Chroma-Biotechnology (China) – Plant extraction, pure compounds.**
  • Chengdu GLP Biotechnology (China) – Forsythin reference standard.**
  • Hubei Yunmei Technology (China) – Extract manufacturer.**

Exclusive Industry Observation: Quality Control and Counterfeit Concern

A critical clinical issue with Forsythia extract bioactive compound formulations is adulteration: cheaper extracts substituting forsythin with less expensive flavonoids (e.g., rutin, quercetin) or adding synthetic anti-inflammatory (diclofenac) to enhance perceived efficacy. Chinese Pharmacopoeia 2025 edition revised the HPLC method for forsythin quantification in raw herb and extract, using dual-wavelength detection (280 nm for forsythin, 330 nm), and also testing for marker adulterants (C18 column gradient). Also now requiring fingerprint similarity to standard reference extract (correlation coefficient >0.95). Manufacturers failing to meet purity (forsythin content <1.5% in extract) or having adulterants are banned from TCM hospital procurement lists.

In 2025, a quality surveillance report (Chinese NMPA) tested 120 forsythia extract samples from 45 suppliers: 16 failed (13%) due to low forsythin (<0.8%), 6 contained undeclared diclofenac sodium. This has increased demand for high-quality compliant suppliers (Jilin Yatai, Jiangxi Boya) and consolidated the market.

Recent Policy and Standard Milestones (2025–2026)

  • January 2025: The Chinese Pharmacopoeia (ChP 2025 edition, Volume I) updated the monograph for Fructus Forsythiae (Lian Qiao), specifying minimum forsythin content 0.15% in raw herb and extract requirement 2.0% (from 1.2%).**
  • April 2025: European Pharmacopoeia (Ph. Eur.) added monograph for Forsythia suspensa extract (standardized to forsythin >2.5%), opening European market for herbal medicinal products (traditional use registration).**
  • July 2025: The World Health Organization (WHO) released “Guidelines on Good Agricultural and Collection Practices for Lian Qiao (Forsythia suspensa)” for starting material quality.
  • October 2025: US Pharmacopeia (USP) published Forsythia Extract Monograph (Forsythin assay HPLC-UV, >3.0%), for dietary supplement industry (anti-inflammatory formulations).**

Conclusion and Strategic Recommendation

For TCM manufacturers, natural product researchers, and herbal extract suppliers, forsythin is a key Forsythia extract bioactive compound with natural anti-inflammatory and antiviral activities. Ethanol extraction is industrial gold standard for pharmaceutical and nutraceutical production (safe solvent, reasonable yield). Methanol extraction for research and reference materials (high purity >98%). Traditional water extraction low yield, phased out. Quality control intensified after adulteration scandals (low forsythin, hidden APIs). Market growth linked to TCM adoption for respiratory infections (seasonal flu, COVID-19 adjuvant), and expansion of standardized herbal products globally. The full QYResearch report provides country-level consumption data by extraction method and formulation, 18 supplier capability assessments (including HPLC purity and residual solvent testing), and a 10-year innovation roadmap for forsythin with semi-synthetic production (biotransformation from precursor) and nanoformulation to enhance bioavailability.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp


カテゴリー: 未分類 | 投稿者huangsisi 17:52 | コメントをどうぞ

コメントを残す

メールアドレスが公開されることはありません。 * が付いている欄は必須項目です


*

次のHTML タグと属性が使えます: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> <img localsrc="" alt="">